The short answer
Chlorthalidone can raise blood calcium, so vitamin D supplementation needs review, particularly at high doses or with other calcium-raising treatments. This does not mean everyone must avoid vitamin D.
What this answer covers
Oral chlorthalidone with supplemental vitamin D2 or D3; active calcitriol and topical analogs are different exposures.
- Supplement or preparation
- Vitamin D
- Medication ingredient
- chlorthalidone
A reported case involved several contributors
A woman taking chlorthalidone developed severe high calcium after parathyroid surgery while also taking calcium carbonate, high-dose vitamin D3 and active calcitriol. She improved after several treatments were stopped and hospital treatment was given. This supports caution but cannot isolate one supplement’s effect.
High calcium is not inevitable
A seven-person mineral-balance study using chlorthalidone or another thiazide found increased calcium retention but unchanged serum calcium. Another small chlorthalidone study deliberately raised low calcium toward normal in hypoparathyroidism with salt restriction and no added vitamin D. These selected settings are not universal safety evidence.
The dose and form matter
The severe case included calcium carbonate and both D3 and calcitriol; carbonate mass is not the same as elemental calcium. It cannot define the risk of an ordinary supplement dose. Check overlapping antacids, calcium and vitamin D products, and distinguish D2 or D3 from prescribed active vitamin D.
Use an individual monitoring plan
Chlorthalidone’s label recommends attention to calcium elevations. Discuss supplement amounts, kidney function and calcium results with the prescriber, especially after parathyroid treatment. A short dosing gap is not an established solution, and these findings do not support universal avoidance or stopping prescribed therapy yourself.
Evidence and practical considerations
Side effects & toxicity
Conditional calcium-elevation concern supported by exact medication evidence, with different-route or mixed-exposure limits and contrary/null human results. No universal dose threshold.
- Exact scope
- Oral chlorthalidone with supplemental vitamin D2 or D3; active calcitriol and topical analogs are different exposures. with Oral chlorthalidone, exact RxCUI2409 IN. No automatic transfer from loop diuretics or another thiazide.
- Medication form and route
- oral medication; oral supplement
What remains uncertain
- No universal risk rate or spacing interval; individual source limitations apply.
Factors that may matter: Preparation and plant part; Dose and duration; Kidney function; Fluid status; Other medicines; Calcium or potassium status.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People treated with oral chlorthalidone
Can cause fluid and electrolyte disturbances, including low potassium and sodium. Reduces urinary calcium excretion and can raise serum calcium; substantial elevation needs evaluation.
How this applies: Exact medication, salt, route, plant part, formulation and clinical endpoint govern applicability.
Exact oral product; not another thiazide or loop diuretic. Chlorothiazide sodium intravenous therapy is a separate route and salt. THALITONE has product-specific bioavailability and should not be assumed dose-for-dose identical to other formulations.
Source 2: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 57-year-old woman three weeks after parathyroidectomy.
Severe hypercalcemia, acute kidney injury and alkalosis improved with stopping several agents and active treatment.
How this applies: Exact medication, salt, route, plant part, formulation and clinical endpoint govern applicability.
One case after parathyroid surgery; multiple contributing agents and simultaneous withdrawals. Carbonate mass must not be relabeled as elemental calcium. Does not establish an ordinary-dose risk rate or isolate D3 from calcitriol.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Seven patients with severe idiopathic hypercalciuria and recurrent calcium oxalate stones.
Urinary calcium decreased and calcium retention increased, while serum calcium and other measured mineral hormones remained unchanged.
How this applies: Exact medication, salt, route, plant part, formulation and clinical endpoint govern applicability.
Seven patients and two medicines, with no drug-specific subgroup details in abstract. Not a calcium or vitamin-D supplement challenge.
Source 4: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Seven hypoparathyroid patients.
Mean serum calcium rose from 8.2 to 9.3 mg/dL while urinary calcium fell, with sustained therapeutic benefit during treatment.
How this applies: Exact medication, salt, route, plant part, formulation and clinical endpoint govern applicability.
Seven selected hypoparathyroid patients; not evidence that self-directed supplementation is safe or a recommendation to replace prescribed vitamin D.
Source 5: regulatory guidance
ods.od.nih.gov · Source check Sep 10, 2026
Population: Users of the specified product
Thiazides reduce urinary calcium and vitamin D increases intestinal calcium absorption; the combination can increase hypercalcemia concern, especially with age, kidney impairment or hyperparathyroidism.
How this applies: Exact medication, salt, route, plant part, formulation and clinical endpoint govern applicability.
Class-level precaution, not a universal incidence or exact dose threshold for either drug.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact-pair article with separately verified drug label, original human evidence and explicit preparation and endpoint limitations. | |
| Research summary published |
Article revision: d60e5320e192a5c4
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.